首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
Scientists said Thursday that a new AIDS vaccine, the first ever declared to protect a significant minority of humans against th
Scientists said Thursday that a new AIDS vaccine, the first ever declared to protect a significant minority of humans against th
admin
2011-06-24
68
问题
Scientists said Thursday that a new AIDS vaccine, the first ever declared to protect a significant minority of humans against the disease, would be studied to answer two fundamental questions: why it worked in some people but not in others, and why those infected despite vaccination got no benefit at all.
The vaccine—known as RV 144, a combination of two genetically engineered vaccines, neither of which had worked before in humans—was declared a qualified success after a six-year clinical trial on more than 16,000 volunteers in Thailand. Those who were vaccinated became infected at a rate nearly one-third lower than the others, the sponsors said Thursday morning.
"I don’t want to use a word like ’breakthrough,’ but I don’t think there’s any doubt that this is a very important result," said Dr. Anthony S. Fauci, the director of the National Institute of Allergy and Infectious Diseases, which is one of the trial’s backers. "For more than 20 years now, vaccine trials have essentially been failures," Dr. Fauci said. "Now it’s like we were groping down an unlit path, and a door has been opened. We can start asking some very important questions."
It will still, however, take years of work before a vaccine that could end the epidemic, which has killed about 25 million people, can even be contemplated. "We often talk about whether a vaccine is even possible," said Mitchell Warren, the executive director of the AIDS Vaccine Advocacy Coalition, or AVAC. "This is not the vaccine mat ends the epidemic and says, ’O.K., let’s move on to something else.’ But it’s a fabulous new step that takes us in a new direction."
In which direction is still unknown. No one—including the researchers from the United States Army, the National Institutes of Health, the Thai Ministry of Public Health and two vaccine companies that tested the vaccine—knows why the vaccine gave even its weak indicator of success.
Experts generally disdain vaccines that do not protect at least 70 to 80 percent of those getting them. And this vaccine did not lower the viral loads of people who were vaccinated but caught the virus anyway, which was baffling because even mismatched vaccines usually do that. Simply repeating the trial to confirm the results would be pointless, experts agreed. The trial, the largest AIDS vaccine trial in history, cost $105 million and followed 16,402 Thai volunteers. The men and women ages 18 to 30 were recruited from two provinces southeast of the capital, Bangkok, from the general population rather than from high-risk groups like drug injectors or sex workers. Half got six doses of two different vaccines; half were given placebos. For ethical reasons, all were offered condoms, taught how to avoid infection and promised lifelong antiretroviral treatment if they got AIDS. They were then regularly tested for three years; 74 of those who got placebos became infected, but only 51 of those who got the vaccines did.
Although the difference was a mere 23 people, Col. Jerome H. Kim, a physician and the manager of the Army’s H.I.V. vaccine program, said it was statistically significant and meant that the vaccine was 31.2 percent effective. The results were surprising because both vaccines, one from the French company Sanofi-Aventis and one developed by Genentech but now licensed to Global Solutions for Infectious Diseases, a nonprofit health group, had failed when used individually. "This came out of the blue," said Chris Viehbacher, Sanofi’s chief executive. Even 31 percent protection "was at least twice as good as our own internal experts were predicting," he added. In 2004, there was so much skepticism about the trial just after it began that 22 top AIDS researchers published an editorial in Science magazine suggesting that it was a waste of money.
One conclusion from the surprising result, said Alan Bernstein, head of the Global HIV Vaccine Enterprise, an alliance of organizations pursuing a vaccine, "is that we’re not doing enough work in humans." Instead of going back to mice or monkeys, he said, different new variants on the two vaccines could be tried on a few hundred people in several countries. This vaccine was designed to combat the most common strain of the virus in Southeast Asia, so it would have to be modified for the strains circulating in Africa and the United States. Sanofi’s vaccine, Alvac-HIV, is a canarypox virus with three AIDS virus genes grafted onto it. Variations of it were tested in several countries; it was safe but not protective. The other vaccine, Aidsvax, was originally made by Genentech and contains a protein found on the surface of the AIDS virus; it is grown in a broth of hamster ovary cells. It was tested in Thai drug users in 2003 and in gay men in North America and Europe but failed. In 2007, two trials of a Merck vaccine in about 4,000 people were stopped early; it not only failed to work but for some men also seemed to increase the risk of infection.
Combining Alvac and Aidsvax was simply a hunch: if one was designed to create antibodies and the other to alert white blood cells, might they work together? One puzzling result—those who became infected had as much virus in their blood whether they got the vaccine or a placebo—suggests that RV 144 does not produce neutralizing antibodies, as most vaccines do, Dr. Fauci said. Antibodies are Y-shaped proteins formed by the body that clump onto invading viruses, blocking the surface spikes with which they attach to cells and flagging them for destruction. Instead, he theorized, it might produce "binding antibodies," which latch onto and empower effector cells, a type of white blood cell attacking the virus. Therefore, he said, it might make sense to screen all the stored Thai blood samples for binding antibodies. "The humbling prospect of this," he said, "is that we may not even be measuring the critical parameter. It may be something you don’t normally associate with protection." Dr. Lawrence Corey, the principal investigator for the HIV Vaccine Trials Network, who was not part of the RV 144 trial, said new work on weakened versions of the smallpox vaccine had produced better pox "spines" that could be substituted for the canarypox. New trials, he added, could be faster and smaller if they were done in African countries where AIDS is more common than in Thailand.
Which of the following can be used to describe the finding of RV 144?
选项
A、unexpected
B、expected
C、controversial
D、insignificant
答案
A
解析
此题是事实题。由第十段可知,RV144是凭着直觉被发现的,因此是意料之外的。
转载请注明原文地址:https://kaotiyun.com/show/q8YO777K
0
专业英语八级
相关试题推荐
Cancunmeans"snakepit"inthelocalMayanlanguage,anditliveduptoitsnameasthehostofanimportantWorldTradeOrganiz
BaruchSpinozawasaDutchphilosopherandreligiousthinkerwhowasbornonNovember24,1632inAmsterdam.HisfamilywasSpan
A、Sharondeclaredthathewouldresign.B、AnIsraeliwomanandherdaughterswerekilledbyPalestiniangunmenC、SomeLikudmemb
Oneofthemajorproblemsofnuclearenergyistheinabilityofscientiststodiscoverasafewaytodisposeoftheradioactive
HarryTrumandidn’tthinkhissuccessorhadtherighttrainingtobepresident."PoorIke---itwon’tbeabitliketheArmy,"
HarryTrumandidn’tthinkhissuccessorhadtherighttrainingtobepresident."PoorIke---itwon’tbeabitliketheArmy,"
Punditswhowanttosoundjudiciousarefondofwarningagainstgeneralizing.Eachcountryisdifferent,theysay,andnoonest
ErnestHemingwaywasoneofthe20thcentury’smostimportantwriters.Hissimple,directstylegreatlyinfluencedotherwriters
HowtoConductEmploymentInterviewsGenerallyspeaking,thepurposeofemploymentinterviewsarethree-fold:a.tomatchac
HowtoConductEmploymentInterviewsGenerallyspeaking,thepurposeofemploymentinterviewsarethree-fold:a.tomatchac
随机试题
因黄磷所致前臂Ⅲ度烧伤,创面清创后除了以下哪种处理外均可
生殖健康内涵不正确的是
A.卫生毒理学常用的实验动物有大、小鼠B.中国地鼠C.豚鼠D.家兔E.狗
下列对城市所具备的基本特征概括,不正确的是()。
【背景资料】某市进行市政工程招标,招标范围限定为本省大型国有企业。甲公司为了中标,联合当地一家施工企业进行投标,并成立了两个投标文件编制小组,一个小组负责商务标编制,一个小组负责技术标编制。在投标的过程中,由于时间紧张,商务标编写组重点
根据《证券法》的规定,中期报告应包括的内容有()。
生硬地植入与剧情无关、与作品审美游离的商业性广告只会招致观众的厌恶.败坏作品的艺术品质。影视创作者倘若能运用智慧,发挥艺术创造性,将广告以美的规律水乳交融般融人剧情内容与艺术理想之中,在两者发生“化学反应”的同时真正实现艺术性的深层内置与隐性交融,这样的广
为什么说学生学习知识的过程是一种特殊的认识过程?
一位研究者认为小学阶段可能是数学自我效能感形成的重要时期。该研究者选取一年级(12名)、三年级(14名)和五年级(14名)小学生,测量其数学自我效能感。经过计算得知三个年级学生的方差相等。统计检验得到F值为3.00。经查表知F0.05(3,40)=2.84
新学期は9月8日から________。
最新回复
(
0
)